logo

LPTX’s Financial Health: Exploring Leap Therapeutics Inc’s Debt-to-Equity Ratio of 1.79

Leap Therapeutics Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $4.79 on 10/30/24, with the lowest value being $0.39 on 03/25/25.

52-week price history of LPTX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Leap Therapeutics Inc’s current trading price is -90.99% away from its 52-week high, while its distance from the 52-week low is 11.29%. The stock’s price range for this period has remained between $0.39 and $4.79. The Healthcare sector company’s shares managed to surpass a trading volume of around 95.21 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.76 million over the last three months.

Financial Performance and Market Capitalization

Leap Therapeutics Inc (LPTX) has experienced a quarterly decline of -85.16% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.55M and boasts a workforce of 54 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9673, with a change in price of -4.1972. Similarly, Leap Therapeutics Inc recorded 1,544,164 in trading volume during the last 100 days, posting a change of -91.05%.

LPTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for LPTX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.

LPTX Stock Stochastic Average

As of today, the raw stochastic average of Leap Therapeutics Inc over the past 50 days is 0.86%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 9.47%. Additionally, the Stochastic %K and %D values for the company were 7.51% and 9.87%, respectively, over the past 20 days.

LPTX Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -84.98%.However, over the last six months, we can see a stronger performance of -84.07%. Over the last 30 days, the price of LPTX has leaped by -10.60%. And in the last five days, it has surged by 4.05%.

Most Popular